Sara Emily Carter, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 393 E 2nd N, Rexburg, ID 83440 Phone: 208-359-9570 |
Ms. Sarah Panting, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 859 S Yellowstone Hwy, Suite 1701, Rexburg, ID 83440 Phone: 208-351-3695 |
Kay H. Williams, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1802 Morningview Dr, Rexburg, ID 83440 Phone: 208-359-1129 Fax: 208-535-1291 |
Karlee Wood Kerr, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 393 E 2nd N, Rexburg, ID 83440 Phone: 208-359-9570 Fax: 208-359-9580 |
Mrs. Sandra Frickey, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1087 Summers Drive, Premier Therapy Associates, Rexburg, ID 83440 Phone: 208-356-4633 Fax: 208-356-4303 |
Heather Linn Rich, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4486 S Cameron Ln, Rexburg, ID 83440 Phone: 208-356-9108 Fax: 208-356-9108 |
News Archive
The research, led by Andrew Whitelaw, Professor of Neonatal Medicine at the University of Bristol, and Ian Pople, paediatric neurosurgeon at North Bristol NHS Trust, has shown that, after a haemorrhage, the fluid inside the ventricles contains substances potentially toxic to the immature brain.
A leading north east industrial illness lawyer has today voiced 'serious concerns' about the number of people still dying after negligent exposure to asbestos and called for renewed efforts to secure justice for mesothelioma sufferers as new statistics show that the death rate has almost tripled in the last 20 years.
A fact check of a dozen often-repeated claims by politicos and interest groups finds that the truth appears "to be taking a vacation," CQ Politics reports. Of the 12 claims, CQ concludes that only one is true, six are misleading and five are downright false.
The radiation oncology team at UH Seidman Cancer Center at UH Geauga Medical Center performed the first-ever prostate cancer treatment on April 3 using a newly approved device. The device, called SpaceOAR System, enhances the efficacy of radiation treatment by protecting organs surrounding the prostate. The device, a temporary injectable gel, received FDA clearance on April 1.
› Verified 3 days ago